St. Francis Cancer Center | St. Francis Cancer Center | Merck MK-3475-355
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1546
clinical-trial-template-default,single,single-clinical-trial,postid-1546,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

Merck MK-3475-355

A Randomized, Double-Blind, Phase III Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer. >Read More

« Available Clinical Trials